• no-js

About MORU

The Mahidol Oxford Tropical Medicine Research Unit (MORU) develops effective and practical means of diagnosing and treating malaria and other neglected diseases such as melioidosis, typhus, TB and leptospirosis.

MORU was established in 1979 as a research collaboration between Mahidol University (Thailand), Oxford University (UK) and the UK’s Wellcome Trust.

MORU’s main office and laboratories are located within the Faculty of Tropical Medicine at Mahidol University in Bangkok, Thailand, with MORU study sites and collaborations across Thailand, Asia and Africa.

MORU is generously supported with significant funding from the Wellcome Trust, our major funding partner. We also receive funding from other trusts and foundations, governments, and multi-lateral donors.

 

Read more about MORU

Recent Publications

How context can impact clinical trials: a multi-country qualitative case study comparison of diagnostic biomarker test interventions. Trials, 20 (1), pp. 111. Article

Impact of 13-Valent Pneumococcal Conjugate Vaccine on Colonisation and Invasive Disease in Cambodian Children. Clin Infect Dis. Article

Modelling population dynamics and seasonal movement to assess and predict the burden of melioidosis. PLoS Negl Trop Dis, 13 (5), pp. e0007380. Article

A decision-theoretic approach to the evaluation of machine learning algorithms in computational drug discovery. Bioinformatics. Article

See all recent publications